Influence of the Sleep Pattern in Patients Submitted to Bariatric Surgery

September 28, 2023 updated by: Cibele Aparecida Crispim, Federal University of Uberlandia

Influence of the Sleep and Chronotype Pattern in Metabolic, Anthropometric and Biochemical Responses in Patients Submitted to Bariatric Surgery

The present study has a prospective, longitudinal and observational character, will be performed with patients attending a private clinic specialized in the treatment of obesity and bariatric surgery. Patients to be analyzed should have a medical indication for bariatric surgery.

Study Overview

Status

Completed

Detailed Description

The patients will be selected for ten months and will be monitored for 12 months there are preoperative period, 3 months, 6 months and 12 months after surgery. Anthropometrical evaluation, biochemistry, polysomnography and sleep questionnaire (Epworth and Psqi) and midpoint sleep questionnaires will be performed to classify the chronotype for sleep pattern evaluation.

Study Type

Observational

Enrollment (Actual)

122

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Minas Gerais
      • Uberlândia, Minas Gerais, Brazil, 38.405-320
        • Cibele Aparecida Crispim

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Bariatric Surgery patients

Description

Inclusion Criteria:

  • Agree to participate in the study and sign the Informed Consent Form (EHIC)
  • Patients submitted to By-pass or Sleeve bariatric surgery or Endossleve
  • Patients with BMI above 35 kg / m².
  • Over the age of 18 and up to 60 years.

Exclusion Criteria:

  • Failure to provide the information necessary for the development of the study.
  • Patients undergo revisional surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Bariatric Surgery patients
Patients attending a private clinic specialized in the treatment of obesity and bariatric surgery. Patients to be analyzed should have a medical indication for bariatric surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight in Kg
Time Frame: Baseline, 3 and 6 months
Anthropometric assessment will be evaluated using weight (kg).
Baseline, 3 and 6 months
BMI in Kg/m²
Time Frame: Baseline, 3 and 6 months
Anthropometric assessment will be evaluated using BMI (kg/m²).
Baseline, 3 and 6 months
Waist Circumference in Centimeters (cm)
Time Frame: Baseline, 3 and 6 months
Anthropometric assessment will be evaluated using waist circumference (cm)
Baseline, 3 and 6 months
Hip Circumference in Centimeters (cm)
Time Frame: Baseline, 3 and 6 months
Anthropometric assessment will be evaluated using hip circumference (cm)
Baseline, 3 and 6 months
Neck Circumference in Centimeters (cm)
Time Frame: Baseline, 3 and 6 months
Anthropometric assessment will be evaluated using neck circumference (cm)
Baseline, 3 and 6 months
Metabolic Parameters - Fasting Glucose (mg/dl)
Time Frame: Baseline and 6 months
Metabolic parameters will be evaluated using fasting glucose (mg/dl)
Baseline and 6 months
Metabolic Parameters - Insulin (mg/dl)
Time Frame: Baseline and 6 months
Metabolic parameters will be evaluated using insulin (mg/dl)
Baseline and 6 months
Metabolic Parameters - Homeostasis Model Assessment for Beta-cell Function (HOMA - IR)
Time Frame: Baseline and 6 months
Values of metabolic parameters will be evaluated using Homeostasis model assessment for beta-cell function (HOMA - IR) according to the standard assessment measurement in mg/dl. Higher values reflect worse insulin resistance
Baseline and 6 months
Metabolic Parameters - Cholesterol (mg/dl)
Time Frame: Baseline and 6 months
Metabolic parameters will be evaluated using Cholesterol (mg/dl)
Baseline and 6 months
Metabolic Parameters - High Density Lipoprotein Cholesterol (HDL - mg/dl)
Time Frame: Baseline and 6 months
Metabolic parameters will be evaluated using High density lipoprotein cholesterol (HDL - mg/dl)
Baseline and 6 months
Metabolic Parameters - Low Density Lipoprotein Cholesterol (LDL - mg/dl)
Time Frame: Baseline and 6 months
Metabolic parameters will be evaluated using low density lipoprotein cholesterol (LDL -mg/dl)
Baseline and 6 months
Metabolic Parameters - Very Low Density Lipoprotein Cholesterol (VLDL - mg/dl)
Time Frame: Baseline and 6 months
Metabolic parameters will be evaluated using Very low density lipoprotein cholesterol (VLDL - mg/dl)
Baseline and 6 months
Metabolic Parameters - Triglycerides (mg/dl)
Time Frame: Baseline and 6 months
Metabolic parameters will be evaluated using Triglycerides (mg/dl)
Baseline and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Food Consumption - Calories (Grams/Day)
Time Frame: Baseline, 3 and 6 months
The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).
Baseline, 3 and 6 months
Food Consumption - Carbohydrate (Grams/Day)
Time Frame: Baseline, 3 and 6 months
The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).
Baseline, 3 and 6 months
Food Consumption - Total Fat (Grams/Day)
Time Frame: Baseline, 3 and 6 months
The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).
Baseline, 3 and 6 months
Food Consumption - Polyunsaturated Fat (Grams/Day)
Time Frame: Baseline, 3 and 6 months
The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).
Baseline, 3 and 6 months
Food Consumption - Monounsaturated Fat (Grams/Day)
Time Frame: Baseline, 3 and 6 months
The food consumption was evaluated by two 24-h recalls at each evaluation moment (Baseline, third and sixth month), with one occurring on a weekday (applied in a private room with the interviewer and participant only) and the other one on the weekend (applied by phone, as done in previous studies).
Baseline, 3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cibele A Crispim, PhD, Federal University of Uberlandia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2017

Primary Completion (Actual)

April 30, 2018

Study Completion (Actual)

April 30, 2019

Study Registration Dates

First Submitted

February 20, 2018

First Submitted That Met QC Criteria

March 29, 2018

First Posted (Actual)

April 2, 2018

Study Record Updates

Last Update Posted (Actual)

April 1, 2024

Last Update Submitted That Met QC Criteria

September 28, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • CEP UFU 2459483/2017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bariatric Surgery Candidate

3
Subscribe